Patient Support Line 1-866-433-8000, Monday-Friday: 8:00 AM to 8:00 PM ET

More proven results. More reasons to believe in KISQALI.
We know that even after being told you're "cancer free," there's still a risk that breast cancer can come back. That's why choosing the right adjuvant therapies or combination treatment plan with your doctor is so important.
KISQALI with an aromatase inhibitor is proven to help reduce the risk of recurrence more than an aromatase inhibitor alone*
*Results from the clinical trial were reviewed at 3 and 5 years:
DID YOU KNOW?
The benefit of KISQALI was shown to increase over time.
When the results were reviewed at 3 years:
KISQALI with an aromatase inhibitor (AI) cut the risk of cancer coming back by 25% compared to an AI alone
91% of people taking KISQALI with an AI were cancer-free, compared with 88% of people taking an AI alone, a difference of 3%
When the results were reviewed at 5 years†:
KISQALI with an AI cut the risk of cancer coming back by 28% compared to an AI alone
86% of people taking KISQALI with an AI were cancer-free, compared with 81% of people taking an AI alone, a difference of 5%
†Results from the 5-year analysis were not designed to detect a false positive or show a difference between treatments.
Leading cancer experts choose ribociclib (KISQALI®)
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), written by leading cancer experts, recommend ribociclib (KISQALI®) + an AI as an option for eligible patients with HR+, HER2- early breast cancer—to help prevent cancer from coming back.
KISQALI is approved for people with HR+, HER2- stage 2 or 3 early breast cancer with a high risk of coming back.
HER2-, human epidermal growth factor receptor 2-negative; HR+, hormone receptor positive.
KISQALI + an AI was studied and proven to reduce the risk of cancer coming back in:

- People who were premenopausal or postmenopausal
- People who had stage 2 or stage 3 eBC with a high risk of coming back
- People with and without cancer in their lymph nodes
Key terms and definitions
Learn more about these terms commonly used by your healthcare team, the medical community, and throughout your treatment journey.
